TNFAIP3 and plasma cell myeloma: Since the role of the tumor suppressor A20 in multiple myeloma has not been investigated yet we aimed to elucidate the functional/mutational properties of A20 in myeloma patients and to add knowledge in a promising target of anti-myeloma treatment.